Learn More
PURPOSE To compare clinical features and outcomes of adults and children reported to have rhabdomyosarcoma. PATIENTS AND METHODS We analyzed data from 1,071 adults (age > 19 years) and 1,529(More)
PURPOSE Two phase II studies assessed the efficacy of vismodegib, a sonic hedgehog (SHH) pathway inhibitor that binds smoothened (SMO), in pediatric and adult recurrent medulloblastoma (MB). (More)